SNH Provider Blog

Foundation Radiology Introduces Innovative New Migraine Treatment Service at Southern New Hampshire Medical Center

Posted by Foundation Medical Providers on Feb 20, 2018 8:43:51 AM

Thanks to the leadership of Dr. Matt Daily, patients struggling with migraine or other chronic headache disorders now have access to a clinically proven treatment for lasting pain relief.

Patients in greater Nashua now have access to Sphenopalatine Neuromodulation or SPG (sphenopalatine ganglion) block, a treatment for chronic headaches and other symptoms. This proven treatment option offers lasting pain relief for those suffering from chronic headache related issues, including:

  • Migraines
  • Trigeminal neuralgia
  • Tension
  • Spinal headaches
  • Atypical facial pain
  • Sinus and cluster headaches

Studies have shown that the SPG, which is located in the back of the nasal cavity and is the only ganglion exposed to the environment, is directly involved in the pathway in numerous forms of headache and, when stimulated, can worsen symptoms. By temporarily disrupting the function of the nerves in the SPG, it is possible to reduce facial pain and headaches leading to significant improvement of symptoms and quality of life.

SNHH_Migraine.jpgRelief through Neuromodulation

Sphenopalatine neuromodulation is used to regulate the SPG’s ability to send signals to and from the brain and other ganglia by blocking its neurotransmitters through a simple, needle-less intranasal approach. After applying an anesthetic spray in each nostril, a fluoroscope is used to help guide a thin, surgical catheter into each nostril. Contrast is used to assure proper placement, followed by the administration of concentrated xylocaine to temporarily “block” the SPG. The entire process takes about 15 minutes and does not require sedation.

 

Results

Studies have shown up to 80% of patients will show significant improvement of their typical symptoms, with two-thirds showing complete or near complete resolution within 24 hours. The majority of patients studied were able to decrease or stop their medications altogether, with 50% having sustained improvement at three months. If significant relief is achieved, the procedure can be repeated and potentially lead to additional long-term relief.

Learn more at more at: SNHhealth.org/migraine

Topics: Foundation Medical Partners

Subscribe to Email Updates

Recent Posts